Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04667468 · ClinicalTrials.gov registry record · Phase 2
Cold Stored Platelet in Hemorrhagic Shock
A Phase 2 study, sponsored by Jason Sperry.
- Completed
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
NCT04667468 is a Phase 2 study that has completed, run by Jason Sperry. The registered enrollment target is 200 participants.
The verdict
NCT04667468, a Phase 2 study, has completed, sponsored by Jason Sperry.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
Study Summary
The Cold Stored Platelet Early Intervention in Hemorrhagic Shock (CriSP-HS) trial is a proposed 3 year, open label, multi-center, randomized trial designed to determine the feasibility, efficacy, and safety of urgent release cold stored platelets (CSP) in patients in hemorrhagic shock. Patients will be randomized to receive either standard care or early infusion of urgent release cold stored platelets (CSP). The proposed pilot study will utilize 5 level-1 trauma centers from within the LITES network and will enroll approximately 200 patients. The primary outcome for the pilot trial is feasibility, with principal secondary clinical outcome of 24 hour mortality.
Interventions
- BIOLOGICAL Standard Care
- BIOLOGICAL Cold Stored Platelets (CSP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2022-06-21 |
| Est. Completion | 2023-11-20 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04667468
The ClinicalTrials.gov registry entry for NCT04667468 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jason Sperry, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard Care is the first listed.
NCT04667468 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04667468 about?
NCT04667468 is a clinical study titled "Cold Stored Platelet in Hemorrhagic Shock". The Cold Stored Platelet Early Intervention in Hemorrhagic Shock (CriSP-HS) trial is a proposed 3 year, open label, multi-center, randomized trial designed to determine the feasibility, efficacy, and safety of urgent release cold stored platelets (CSP) in patients in hemorrhagic shock. Patients will...
What is the current status of trial NCT04667468?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2022-06-21. Estimated completion is 2023-11-20.
What interventions are being tested in trial NCT04667468?
The interventions under investigation include: Standard Care (BIOLOGICAL), Cold Stored Platelets (CSP) (BIOLOGICAL).
Who is sponsoring clinical trial NCT04667468?
This trial is sponsored by Jason Sperry, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.